<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04772027</url>
  </required_header>
  <id_info>
    <org_study_id>APHP200141</org_study_id>
    <secondary_id>2020-A02090-39</secondary_id>
    <nct_id>NCT04772027</nct_id>
  </id_info>
  <brief_title>Motor Parameters in Patients With Limb Girdle Muscular Dystrophy</brief_title>
  <acronym>EIDY</acronym>
  <official_title>Characterization and Identification of Motor Parameters Using Instrumental Assessment in Patients With Limb Girdle Muscular Dystrophy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of the study is to perform 2-year follow up with motor parameters&#xD;
      evolution using instrumental assessments in patients with limb girdle muscular dystrophie,&#xD;
      and to identify which motor parameters are sensitive to change.&#xD;
&#xD;
      The secondary objectives of the study are:&#xD;
&#xD;
        -  to describe the changes of the parameters obtained from instrumental evaluations in&#xD;
           comparison with the changes obtained from clinical assessments.&#xD;
&#xD;
        -  to characterize the muscular impairments, the biomechanical gait disorders, the standing&#xD;
           postural control disorders, the biomechanical upper limb disorders in spatial&#xD;
           exploration, the limitation of upper limb capacities, the fatigue, the endurance, the&#xD;
           patients' participation to their activities and their quality of life, in comparison&#xD;
           with a healthy paired population.&#xD;
&#xD;
        -  to highlight the relationships between muscular assessment parameters, biomechanical&#xD;
           gait parameters, standing posture control and upper limb spatial exploration.&#xD;
&#xD;
        -  to highlight the relationships between data from instrumental assessments and data from&#xD;
           clinical assessments.&#xD;
&#xD;
        -  to highlight the relationships between instrumental assessments data and clinical&#xD;
           assessments data on one side, and features of patients (age, sex, duration since&#xD;
           diagnosis, type of LGMD, rehabilitation in follow-up, sportive practices...) on the&#xD;
           other side.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a monocentric study in which 2 sub-groups of people will be enrolled: LGMD patients&#xD;
      and healthy volunteers. Each enrolled LGMD patient will have 5 visits during 2 years, one&#xD;
      baseline visit and four half-yearly visits. Each enrolled healthy volunteer will have one&#xD;
      planned visit only. The duration of enrollments will last 20 months.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2021</start_date>
  <completion_date type="Anticipated">January 2025</completion_date>
  <primary_completion_date type="Anticipated">January 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline on maximal strength</measure>
    <time_frame>Assessed at 6 months, 12 months, 18 months and 24 months</time_frame>
    <description>Maximal strength and muscular activation of knee extensors will be evaluated by isometric test with an isokinetic dynamometer (Biodex Medical Systems Inc., Shirley, New York, USA).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline on peak hip flexion</measure>
    <time_frame>Assessed at 6 months, 12 months, 18 months and 24 months</time_frame>
    <description>Hip flexion peak during gait will be evaluated with tridimensional gait analysis with an optoelectronic system ((Optitrack system, Natural Point Inc. Corvallis, OR, USA)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline on speed of center of pression during standing postural control</measure>
    <time_frame>Assessed at 6 months, 12 months, 18 months and 24 months</time_frame>
    <description>Speed of center of pression will be measured by force platforms (AMTI, Advanced Mechanical Technology).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline on elbow peak extension during upper limb spatial exploration</measure>
    <time_frame>Assessed at 6 months, 12 months, 18 months and 24 months</time_frame>
    <description>Elbow peak extension will be measured biomechanically with an optoelectronic system during upper limb spatial exploration (Optitrack system, Natural Point Inc. Corvallis, OR, USA)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline on muscular parameters</measure>
    <time_frame>Assessed at 6 months, 12 months, 18 months and 24 months</time_frame>
    <description>Maximal strength during isometric tests of hip, knee flexors, ankle and maximal grip strength. (Biodex Medical Systems Inc., Shirley, New York, USA) Muscular fatigue</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Joint kinematic parameters: change from baseline on gait speed</measure>
    <time_frame>Assessed at 6 months, 12 months, 18 months and 24 months</time_frame>
    <description>Spatio-temporal from biomechanical gait analysis: an optoelectronic system (Optitrack system, Natural Point Inc. Corvallis, OR, USA) will be used.&#xD;
Spatio-temporal = speed (m/s)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Joint kinematic parameters: change from baseline on step length</measure>
    <time_frame>Assessed at 6 months, 12 months, 18 months and 24 months</time_frame>
    <description>Spatio-temporal from biomechanical gait analysis: an optoelectronic system (Optitrack system, Natural Point Inc. Corvallis, OR, USA) will be used.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Joint kinematic parameters: change from baseline on cadence</measure>
    <time_frame>Assessed at 6 months, 12 months, 18 months and 24 months</time_frame>
    <description>Spatio-temporal from biomechanical gait analysis: an optoelectronic system (Optitrack system, Natural Point Inc. Corvallis, OR, USA) will be used.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Joint kinematic parameters: change from baseline on step width</measure>
    <time_frame>Assessed at 6 months, 12 months, 18 months and 24 months</time_frame>
    <description>Spatio-temporal from biomechanical gait analysis: an optoelectronic system (Optitrack system, Natural Point Inc. Corvallis, OR, USA) will be used.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Joint kinematic parameters: change from baseline on % single support phase of gait cycle</measure>
    <time_frame>Assessed at 6 months, 12 months, 18 months and 24 months</time_frame>
    <description>Spatio-temporal from biomechanical gait analysis: an optoelectronic system (Optitrack system, Natural Point Inc. Corvallis, OR, USA) will be used.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Joint kinematic parameters: change from baseline on % swing phase of gait cycle</measure>
    <time_frame>Assessed at 6 months, 12 months, 18 months and 24 months</time_frame>
    <description>Spatio-temporal from biomechanical gait analysis: an optoelectronic system (Optitrack system, Natural Point Inc. Corvallis, OR, USA) will be used.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Joint kinematic parameters: change from baseline on % support phase of gait cycle</measure>
    <time_frame>Assessed at 6 months, 12 months, 18 months and 24 months</time_frame>
    <description>Spatio-temporal from biomechanical gait analysis: an optoelectronic system (Optitrack system, Natural Point Inc. Corvallis, OR, USA) will be used.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline on kinetic gait parameters</measure>
    <time_frame>Assessed at 6 months, 12 months, 18 months and 24 months</time_frame>
    <description>Kinetic parameters will be obtained from biomechanical gait analysis with AMTI force plateforms (Advanced Mechanical Technology, Waterton, MA, USA).&#xD;
This includes peak of ground reaction force in antero-posterior and vertical axis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline on standing postural control parameters: COP displacements</measure>
    <time_frame>Assessed at 6 months, 12 months, 18 months and 24 months</time_frame>
    <description>Parameters of stabilization and postural orientation during postural control assessment on force platforms (AMTI, Advanced Mechanical Technology), Waterton, MA, USA). Parameters of stabilization include:&#xD;
Mean and maximal speed of center of pression (COP) displacements.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline on standing postural control parameters: elliptic surface</measure>
    <time_frame>Assessed at 6 months, 12 months, 18 months and 24 months</time_frame>
    <description>Parameters of stabilization and postural orientation during postural control assessment on force platforms (AMTI, Advanced Mechanical Technology), Waterton, MA, USA). Parameters of stabilization include:&#xD;
Elliptic surface covering 90% of COP positions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline on standing postural control parameters: Amplitude of COP</measure>
    <time_frame>Assessed at 6 months, 12 months, 18 months and 24 months</time_frame>
    <description>Parameters of stabilization and postural orientation during postural control assessment on force platforms (AMTI, Advanced Mechanical Technology), Waterton, MA, USA). Parameters of stabilization include:&#xD;
Amplitude of COP shift in anteroposterior and mediolateral axis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline on standing postural control parameters: Romberg quotient</measure>
    <time_frame>Assessed at 6 months, 12 months, 18 months and 24 months</time_frame>
    <description>Parameters of stabilization and postural orientation during postural control assessment on force platforms (AMTI, Advanced Mechanical Technology), Waterton, MA, USA). Parameters of stabilization include:&#xD;
Romberg quotient.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline on standing postural orientation parameters</measure>
    <time_frame>Assessed at 6 months, 12 months, 18 months and 24 months</time_frame>
    <description>Parameters of stabilization and postural orientation during postural control assessment on force platforms (AMTI, Advanced Mechanical Technology), Waterton, MA, USA).&#xD;
The orientation parameters include: mean position of COP in anteroposterior and mediolateral axis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline on standing postural orientation parameters: limb loading ratio</measure>
    <time_frame>Assessed at 6 months, 12 months, 18 months and 24 months</time_frame>
    <description>Parameters of stabilization and postural orientation during postural control assessment on force platforms (AMTI, Advanced Mechanical Technology), Waterton, MA, USA).&#xD;
The orientation parameters include: limb loading ratio.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline on drinking task with left and right upper limb: velocity and movement time</measure>
    <time_frame>Assessed at 6 months, 12 months, 18 months and 24 months</time_frame>
    <description>The spatio-temporal parameters will be obtained from biomechanical analysis with an optoelectronic system (Optitrack system, Natural Point Inc. Corvallis, OR, USA) including:&#xD;
Velocity and movement time (Total movement time / Peak velocity/ Mean velocity)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline on drinking task with left and right upper limb: movement strategy</measure>
    <time_frame>Assessed at 6 months, 12 months, 18 months and 24 months</time_frame>
    <description>The spatio-temporal parameters will be obtained from biomechanical analysis with an optoelectronic system (Optitrack system, Natural Point Inc. Corvallis, OR, USA) including:&#xD;
Movement strategy (Time to peak velocity / time to first peak)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline on drinking task with left and right upper limb: smoothness and coordination movement</measure>
    <time_frame>Assessed at 6 months, 12 months, 18 months and 24 months</time_frame>
    <description>The spatio-temporal parameters will be obtained from biomechanical analysis with an optoelectronic system (Optitrack system, Natural Point Inc. Corvallis, OR, USA) including:&#xD;
Smoothness and coordination movement (number of movements units / interjoint coordination)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline on drinking task with left and right upper limb: trunk displacement</measure>
    <time_frame>Assessed at 6 months, 12 months, 18 months and 24 months</time_frame>
    <description>The spatio-temporal parameters will be obtained from biomechanical analysis with an optoelectronic system (Optitrack system, Natural Point Inc. Corvallis, OR, USA) including:&#xD;
Trunk displacement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline on drinking task with left and right upper limb: angular joint</measure>
    <time_frame>Assessed at 6 months, 12 months, 18 months and 24 months</time_frame>
    <description>The spatio-temporal parameters will be obtained from biomechanical analysis with an optoelectronic system (Optitrack system, Natural Point Inc. Corvallis, OR, USA) including:&#xD;
Angular joint</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline on 6 minutes walking test distance</measure>
    <time_frame>Assessed at 6 months, 12 months, 18 months and 24 months</time_frame>
    <description>6 minutes walking test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline on the Berg Balance Scale score</measure>
    <time_frame>Assessed at 6 months, 12 months, 18 months and 24 months</time_frame>
    <description>The Berg Balance Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline on Brooke Upper Extremity Scale score</measure>
    <time_frame>Assessed at 6 months, 12 months, 18 months and 24 months</time_frame>
    <description>Brooke Upper Extremity Scale score for upper extremity capacities.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline on locomotor</measure>
    <time_frame>Assessed at 6 months, 12 months, 18 months and 24 months</time_frame>
    <description>Questionnaires Abiloco</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline on upper limb capacities</measure>
    <time_frame>Assessed at 6 months, 12 months, 18 months and 24 months</time_frame>
    <description>Questionnaires Abilhand</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline on patient occupations</measure>
    <time_frame>Assessed at 6 months, 12 months, 18 months and 24 months</time_frame>
    <description>Patient occupations assessed by COPM (Canadian Occupational Performance Measure). The measurement will be from 1 (not at all performant) to 10 (very performant) as score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline on MRC (Medical Research Council) score on flexors and extensors of lower and upper limb</measure>
    <time_frame>Assessed at 6 months, 12 months, 18 months and 24 months</time_frame>
    <description>Testing MRC (Medical Research Council), a scale for muscle power. The muscle scale grades muscle power on a scale of 0 to 5 in relation to the maximum expected for that muscle.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline on Fatigue Severity Scale (FSS) score</measure>
    <time_frame>Assessed at 6 months, 12 months, 18 months and 24 months</time_frame>
    <description>Questionnaire Fatigue Severity Scale (FSS) for fatigue assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline on number of fall risks</measure>
    <time_frame>Assessed at 6 months, 12 months, 18 months and 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline on number of physiotherapy sessions per week</measure>
    <time_frame>at baseline, 6 months, 12 months, 18 months and 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline on number of sports practice per week</measure>
    <time_frame>at baseline, 6 months, 12 months, 18 months and 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline on Individualized Neuromuscular Quality of Life Questionnaire (INQoL)</measure>
    <time_frame>Assessed at 6 months, 12 months, 18 months and 24 months</time_frame>
    <description>Quality of life questionnaire: INQoL</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Limb Girdle Muscular Dystrophies</condition>
  <arm_group>
    <arm_group_label>Muscular dystrophies group</arm_group_label>
    <description>40 patients with limb girdle muscular dystrophie</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Comparator group</arm_group_label>
    <description>40 healthy volunteers without neuromuscular or squeletic disorder</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Population with limb girdle muscular dystrophie for 2-year longitudinal follow-up in&#xD;
        Raymond Poincaré hospital. The 4 most common types of diseases: calpainopathy,&#xD;
        sarcoglycanopathy, dysferlinopathy and alpha-dystroglycanopathy.&#xD;
&#xD;
        Control group: healthy population without neuromuscular or squeletic disorder.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  For limb girdle muscular dystrophie group:&#xD;
&#xD;
               -  Patients diagnosed limb girdle muscular dystrophie;&#xD;
&#xD;
               -  Aged between 18 and 70 years;&#xD;
&#xD;
               -  Covered by the French social security scheme;&#xD;
&#xD;
               -  Patient able to maintain upright position alone;&#xD;
&#xD;
               -  Able to walk at least 10 meters and 6 minutes consecutively without help.&#xD;
&#xD;
          -  For Volunteer group:&#xD;
&#xD;
               -  Adult (18 to 70 years) without neuromuscular or squeletic disorder.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        § For all:&#xD;
&#xD;
          -  Without associated neuromuscular disorders such as respiratory or muscular-squeletic&#xD;
             diseases, apart from the consequences of dystrophy;&#xD;
&#xD;
          -  Contraindication to the tests;&#xD;
&#xD;
          -  Noncontrol cardiac rhythm disorders;&#xD;
&#xD;
          -  Lying down position intolerance due to severe respiratory troubles;&#xD;
&#xD;
          -  Pregnant or breastfeeding woman.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Céline BONNYAUD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Laboratoire d'analyse du mouvement, Service d'explorations fonctionnelles, Hôpital Raymond Poincaré, APHP</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Samuel POUPLIN</last_name>
    <role>Study Director</role>
    <affiliation>Plateforme Nouvelles Technologies, Hôpital Raymond Poincaré, APHP</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Céline BONNYAUD, PhD</last_name>
    <phone>+33 (0)1 71 14 49 21</phone>
    <email>celine.bonnyaud@aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Samuel POUPLIN</last_name>
    <phone>+33 (0)1 47 10 70 61</phone>
    <email>samuel.pouplin@aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Laboratoire d'analyse du mouvement, Service d'exploration fonctionnelles, Hôpital Raymond Poincaré, APHP</name>
      <address>
        <city>Garche</city>
        <zip>92380</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 7, 2021</study_first_submitted>
  <study_first_submitted_qc>February 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 25, 2021</study_first_posted>
  <last_update_submitted>May 10, 2021</last_update_submitted>
  <last_update_submitted_qc>May 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Limb Girdle Muscular Dystrophies (LGMD)</keyword>
  <keyword>motricity</keyword>
  <keyword>instrumental assessment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscular Dystrophies</mesh_term>
    <mesh_term>Muscular Dystrophies, Limb-Girdle</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

